Review for NCCAM is overdue

Science

Volumn 313, Issue 5785, 2006, Pages 301-302

  Marcus, Donald M ^a   Grollman, Arthur P ^b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEDICINE;

ADVISORY COMMITTEE; ALTERNATIVE MEDICINE; EVALUATION; FUNDING; HEALTH CARE ORGANIZATION; PRIORITY JOURNAL; RESEARCH; REVIEW; UNITED STATES; ARTICLE; BUDGET; CLINICAL TRIAL; DIET SUPPLEMENTATION; ECONOMICS; FINANCIAL MANAGEMENT; HUMAN; MEDICAL RESEARCH; ORGANIZATION; ORGANIZATION AND MANAGEMENT; PHYTOTHERAPY; POLICY; POLITICS; QUALITY CONTROL; STANDARD;

ADVISORY COMMITTEES; BIOMEDICAL RESEARCH; BUDGETS; CLINICAL TRIALS; COMPLEMENTARY THERAPIES; DIETARY SUPPLEMENTS; HUMANS; INSTITUTE OF MEDICINE (U.S.); NATIONAL INSTITUTES OF HEALTH (U.S.); PHYTOTHERAPY; POLITICS; PUBLIC POLICY; QUALITY CONTROL; RESEARCH SUPPORT; UNITED STATES;

EID: 33746522518     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.1126978     Document Type: Review

References (30)

1. J. H. Young, Bull. Hist. Med. 72, 279 (1998).
2. E. Marshall, Science 265, 2000 (1994).
3. S. Budiansky, U.S. News World Rep., 17 July 1995, p. 48; (www.usnews.com/usnews/culture/articles/950717/archive_032434.htm).
4. J. Mervis, Science 311, 28 (2006).
5. G. Vogel, Science 278, 378 (1997).
6. J. Couzin, Science 282, 2175 (1998).
7. National Advisory Council for Complementary and Alternative Medicine (NACCAM) (http://nccam.nih.gov/about/advisory/naccam/charter.htm).
8. J. D. Berman, S. E. Straus, Annu. Rev. Med. 55, 239 (2004).
9. "Expanding horizons of health care: Strategic plan 2005-2009" [National Center for Complementary and Alternative Medicine (NCCAM), U.S. Department of Health and Human Services, National Institutes of Health, Bethesda, MD, 2005].
10. J. S. Markowitz et al. JAMA 290, 1500 (2003).
11. R. B. Turner et al., N. Engl. J. Med. 353, 341 (2005).
12. S. Bent et al., N. Engl. J. Med. 354, 557 (2006).
13. G. Kolata, New York Times, 28 July 2005.
14. R. J. Blendon, C. M. DesRoches, J. M. Benson, M. Brodie, D. E. Altman, Arch. Intern. Med. 161, 805 (2001).
15. P. A. G. M. De Smet, Clin. Pharmacol. Ther. 76, 1 (2004).
16. M. Elvin-Lewis, Adv. Food Nutr. Res. 50, 219 (2005).
17. NCCAM, Policy announcement on the quality of natural products, 2003; (http://nccam.nih.gov/research/policies/bioactive.htm).
18. W. Sampson, N. Engl. J. Med. 353, 337 (2005).
19. "NIH launches large clinical trial on EDTA chelation therapy for coronary artery disease," press release, 30 August 2002;(http://nccam.mh. gov/news/2002/chetation/pressrelease.htm).
20. "Questions and answers about chelation therapy," American Heart Association (www.americanheart.org/presenter.jhtml?identifier=3000843).
21. E. Ernst, Am. Heart J. 140, 139 (2000).
22. M. L. Knudtson et al., JAMA 287, 481 (2002).
23. M. V. Villaruz, A. Dans, F. Tan, Cochrane Database Syst. Rev. 2002(4), CD002785 (2002).
24. D. M. R. Seely, P. Wu, E. J. Mills, BMC Cardiovasc. Disord. 5, 32 (2005).
25. Gemcitabine compared with pancreatic enzyme therapy plus specialized diet (Gonzalez regimen) in treating patients who have stage II, stage III, or stage IV pancreatic cancer (http://clinicaltrials.gov).
26. Metabolic therapy, American Cancer Society (www.cancer.org).
27. S. Green (www.quackwatch.org/01QuackeryRelated Topics/Cancer/kg.html).
28. "Alternative medicine: Expanding medical horizons: A report to the National Institutes of Health on alternative medical systems and practices in the United States," Workshop on Alternative Medicine, Chantilly, VA, 14 to 16 September 1992 (Government Printing Office, Washington, DC, 1995).
29. Committee on the Use of Complementary and Alternative Medicine by the American Public, Complementary and Alternative Medicine in the United States (Institute of Medicine, The National Academies Press, Washington, DC, 2005), chap. 9.
30. E. Stokstad, Science 288, 1568 (2000).